| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-11 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.45 | 6e-11 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.41 | 4e-09 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.28 | 1e-07 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.24 | 7e-07 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-06 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.3 | 8e-05 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0001 |